We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
-11.9%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.02B
AUM Growth
-$224M
Cap. Flow
-$66M
Cap. Flow %
-6.44%
Top 10 Hldgs %
37.29%
Holding
460
New
60
Increased
97
Reduced
133
Closed
90

Top Buys

Rank Stock Value
1
ERF
Enerplus Corporation
ERF
+$40.3M
2
EXE
Expand Energy Corp
EXE
+$31.8M
3
OVV icon
Ovintiv
OVV
+$27M
4
AAPL icon
Apple
AAPL
+$11.9M
5
CI icon
Cigna
CI
+$8.17M

Sector Composition

Rank Sector Weight
1 Energy 35.74%
2 Healthcare 12.12%
3 Technology 11.16%
4 Financials 9.37%
5 Consumer Discretionary 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
76
Alphabet (Google) Class A
GOOGL
$3.91T
$2.26M 0.22%
20,720
+2,700
+15% +$318K
LMT icon
77
Lockheed Martin
LMT
$134B
$2.19M 0.21%
5,101
-57
-1% -$25K
VET icon
78
Vermilion Energy
VET
$1.73B
$2.15M 0.21%
112,943
+200
+0.2% +$4.17K
ZWS icon
79
Zurn Elkay Water Solutions
ZWS
$8.07B
$2.14M 0.21%
78,449
+52,244
+199% +$1.58M
HRMY icon
80
Harmony Biosciences
HRMY
$2.04B
$2.12M 0.21%
43,430
-240
-0.5% -$10.8K
CBRG
81
DELISTED
Chain Bridge I Class A Ordinary Shares
CBRG
$2.11M 0.21%
212,020
AVTA
82
DELISTED
Avantax, Inc. Common Stock
AVTA
$2.08M 0.2%
+112,985
New +$2.05M
ITCI
83
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.08M 0.2%
36,414
-4,141
-10% -$235K
FRME icon
84
First Merchants
FRME
$2.72B
$2.06M 0.2%
57,679
+5,495
+11% +$216K
MTDR icon
85
Matador Resources
MTDR
$6.31B
$2.02M 0.2%
43,244
-34,117
-44% -$1.85M
DEVS
86
DELISTED
DevvStream Corp
DEVS
$2.01M 0.2%
20,260
LNTH icon
87
Lantheus
LNTH
$6.82B
$1.91M 0.19%
28,927
+11,907
+70% +$751K
AXNX
88
DELISTED
Axonics, Inc. Common Stock
AXNX
$1.9M 0.19%
33,456
-31,690
-49% -$1.74M
AVGO icon
89
Broadcom
AVGO
$1.82T
$1.86M 0.18%
38,230
-440
-1% -$24.7K
CNNE icon
90
Cannae Holdings
CNNE
$647M
$1.78M 0.17%
91,973
+36,000
+64% +$755K
JNJ icon
91
Johnson & Johnson
JNJ
$634B
$1.77M 0.17%
9,970
+3
+0% +$535
CDW icon
92
CDW
CDW
$17.1B
$1.76M 0.17%
11,196
+2,322
+26% +$390K
SWAV
93
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$1.75M 0.17%
+9,159
New +$1.62M
SSB icon
94
SouthState Bank Corp
SSB
$10.4B
$1.75M 0.17%
22,682
-911
-4% -$71K
MDC
95
DELISTED
M.D.C. Holdings, Inc.
MDC
$1.73M 0.17%
+53,670
New +$1.92M
IPG
96
DELISTED
Interpublic Group of Companies
IPG
$1.72M 0.17%
62,280
-353
-0.6% -$11.2K
MP icon
97
MP Materials
MP
$7.35B
$1.71M 0.17%
53,353
-12,457
-19% -$503K
RSP icon
98
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$1.69M 0.17%
12,605
-682
-5% -$99.8K
OPCH icon
99
Option Care Health
OPCH
$3.4B
$1.69M 0.16%
+60,779
New +$1.73M
BKU icon
100
Bankunited
BKU
$3.38B
$1.62M 0.16%
45,594
-45,560
-50% -$1.8M

Similar funds

Advisory Research's Q2 2022 Portfolio in Review

As of Q2 2022, Advisory Research held 460 positions worth $1.02B, down 18% from $1.25B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Advisory Research withdrew a net $66M in Q2 2022, closing 90 positions and reducing 133 holdings. Its most notable exit was Coterra Energy, an estimated $24M position sold in full.

By sector, the portfolio is most concentrated in Energy at 36% of assets, up from 34% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Advisory Research opened a new position in Enerplus Corporation worth $38.7M.

  • Advisory Research's largest Q2 2022 buy was Enerplus Corporation: 2,926,378 shares worth $38.7M.
  • Advisory Research added most to Ovintiv in Q2 2022, an estimated $27M increase.
  • Advisory Research's biggest Q2 2022 reduction was Devon Energy, cutting an estimated $34.5M.
  • Advisory Research fully exited Coterra Energy in Q2 2022, selling an estimated $24M.
  • Advisory Research's ten largest holdings make up 37% of its $1.02B portfolio in Q2 2022.
  • Advisory Research opened 60 new positions and closed 90 in Q2 2022.
  • Advisory Research's portfolio value fell 18% quarter-over-quarter to $1.02B.

Based on Advisory Research's 13F filing for Q2 2022, filed 15 Aug 2022.